NEW YORK (GenomeWeb) – Great Basin Scientific announced today it has priced a public offering expected to raise $6 million in gross proceeds.

The Salt Lake City, Utah-based molecular diagnostics company intends to use the offering to fund its research and development activities, for sales and marketing expenses, to support the manufacture of additional analyzers, to expand its manufacturing capacity, and for general corporate purposes including working capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.